Emergent biosolutions inc. (EBS)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues:
Total revenues

1,106,000

782,400

560,900

488,800

489,331

404,466

312,745

281,888

273,384

286,171

234,786

Operating expenses:
Cost of product sales and contract development and manufacturing services

433,500

322,300

187,700

126,300

107,486

101,963

62,127

46,077

42,171

47,114

46,262

Research and development

226,200

142,800

97,400

106,900

119,186

104,721

119,933

120,226

124,832

89,295

74,588

Selling, general and administrative

273,500

202,500

142,900

143,100

121,145

108,594

87,883

76,018

74,282

76,205

73,786

Amortization of Intangible Assets

58,700

25,000

8,600

7,000

-

-

-

-

-

-

-

Total operating expenses

991,900

692,600

436,600

383,300

-

-

-

-

-

-

-

Impairment of in-process research and development

-

-

-

-

-

-

-

9,600

0

0

-

Loss from operations

114,100

89,800

124,300

105,500

141,514

89,188

42,802

29,967

32,099

73,557

40,150

Other (expense) income:
Interest income

-

-

-

-

572

320

139

134

105

832

1,418

Interest expense

38,400

9,900

6,600

7,600

6,523

8,240

0

6

0

0

7

Other expense, net

1,700

1,600

900

1,300

153

2,926

426

1,970

-261

-1,023

-50

Total other expense, net

-36,700

-8,300

-5,700

-6,300

-5,798

-4,994

565

2,098

-156

-191

1,361

Loss before provision for income taxes

77,400

81,500

118,600

99,200

135,716

84,194

43,367

32,065

31,943

73,366

41,511

Income tax benefit

22,900

18,800

36,000

36,700

44,300

29,928

13,108

13,922

15,830

26,182

14,966

Net income from continuing operations

-

-

-

62,500

91,416

54,266

-

-

-

-

-

Net loss from discontinued operations

-

-

-

-10,700

-28,546

-17,525

-

-

-

-

-

Net income

-

-

-

-

-

36,741

30,259

18,143

16,113

47,184

26,545

Net loss attributable to noncontrolling interest

-

-

-

-

-

-

-876

-5,381

-6,906

-4,514

-4,599

Net Income (Loss) Attributable to Parent

54,500

62,700

82,600

51,800

62,870

-

31,135

23,524

23,019

51,698

31,144

Earnings Per Share [Abstract]
Net income (loss) per share - basic:
Net income per share from continuing operations-basic (in dollars per share)

-

-

-

1.56

2.37

1.45

-

-

-

-

-

Net loss per share from discontinued operations-basic (in dollars per share)

-

-

-

-0.27

-0.74

-0.47

-

-

-

-

-

Basic (in dollars per share)

1.06

1.25

1.98

1.29

1.63

0.98

0.86

0.65

0.65

1.63

1.02

Net income (loss) per share - diluted:
Net income from continuing operations-diluted (in dollars per share)

-

-

-

1.35

2.02

1.26

-

-

-

-

-

Net income (loss) per share from discontinued operations-diluted (in dollars per share)

-

-

-

-0.22

-0.61

-0.38

-

-

-

-

-

Diluted (in dollars per share)

1.04

1.22

1.71

1.13

1.41

0.88

0.85

0.65

0.64

1.59

0.99

Shares used in computing loss per share
Basic (in shares)

51,500

50,100

41,800

40,200

38,595

37,344

36,201

36,080

35,658

31,782

30,444

Diluted (in shares)

52,400

51,400

50,300

49,300

47,255

45,802

36,747

36,420

36,206

32,539

31,375

Product sales, net
Total revenues

903,500

606,500

421,500

296,300

328,969

281,845

257,922

215,879

202,409

251,381

217,172

Contract Manufacturing [Member]
Total revenues

80,000

98,900

68,900

49,100

42,968

30,944

0

0

-

-

-

Contracts and grants
Total revenues

122,500

77,000

70,500

143,400

117,394

91,677

54,823

66,009

70,975

34,790

17,614